Office-Based Laryngology.

Otolaryngologic clinics of North America 2025 Vol.58(4) p. 623-640

Lamm SA, Buckmire RA, Shah RN

관련 도메인

Abstract

Injection laryngoplasty was first described by Dr Charles Bruening in 1911 with the injection of paraffin for vocal cord paralysis. The most common indication for injection laryngoplasty is glottic insufficiency causing dysphonia and/or dysphagia and aspiration. Etiologies of glottic insufficiency include vocal fold immobility, vocal fold hypomobility, sulcus vocalis/vocal scar, and vocal fold atrophy. In-office laryngology procedures, made possible by advancements in equipment and endoscopy, offer numerous benefits including cost-effectiveness, avoidance of general anesthesia, efficiency, and a high safety profile. These procedures can be easily performed in carefully selected patients.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 cord scispacy 1
합병증 glottic insufficiency scispacy 1
기법 endoscopy 내시경 dict 1
질환 paralysis C0522224
Paralysed
scispacy 1
질환 glottic insufficiency scispacy 1
질환 dysphonia C1527344
Dysphonia
scispacy 1
질환 dysphagia C0011168
Deglutition Disorders
scispacy 1
질환 vocal fold hypomobility scispacy 1
질환 atrophy C0333641
Atrophic
scispacy 1
질환 laryngoplasty scispacy 1
기타 Dr Charles Bruening in scispacy 1
기타 sulcus vocalis/vocal scispacy 1
기타 patients scispacy 1

MeSH Terms

Humans; Laryngoplasty; Vocal Cord Paralysis; Ambulatory Surgical Procedures; Laryngoscopy; Dysphonia; Vocal Cords

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문